Research and methods −Artificial intelligence (AI) is opening up new possibilities for public health research. At the Robert Koch Institute (RKI), AI is used in research to be able to analyse health data more efficiently, predict disease outbreaks more accurately and better support evidence-based …
The aim of the AntibioResDE (Antibiotic Resistance in Germany) project is to provide up-to-date information on antibiotic resistance in Germany on an electronic platform in order to simplify access to resistance data for clinical practice. AntibioResDE can thus help to prevent the development of …
Major biological incidents are rare. However, the consequences for public health may be severe if hazardous biological agents are released. Recognising, assessing and managing these events presents challenges for all responsible parties, including the police, fire brigade and public health services. …
From March 2nd to March 7th, a ZIG 2 and ZIG 4 research scientists traveled to Guinea to collaborate with the Institut National de Santé Publique (INSP) as part of the Vaccine Readiness in Sub-Saharan Africa (VRSA) project. The project’s current phase focuses on hepatitis B prevalence and immunity …
The Robert Koch Institut (RKI) ist he German Federal Government’s central institution in the field of biomedicine. Its core tasks include detecting, preventing and combating infectious diseases and improving the health of the population in Germany. The focus is on research. The RKI advises the …
As part of the Global Protection Programme (GHPP), funded by the German Federal Ministry of Health, the Robert Koch Institute (RKI) has supported the “Partnership to Improve Patient Safety and Quality – PASQUALE” project in Guinea since 2019 (following its first funding phase within the program …
Abstract:Background: Self-perceived oral health reflects the individual’s point of view. Both subjective (e.g. pain, aesthetic aspects) and objective criteria (e.g. oral diseases, functional limitations) are included in the assessment. Oral diseases interact with noncommunicable diseases such as …
Since 1 January 2025, the EU Reference Laboratory for Public Health on "High-risk, emerging and zoonotic bacterial pathogens" (EURL-PH-HEZB) has launched its activities. It is one of the new EU reference laboratories for public health (EURLs). The EURL is led by a consortium coordinated by the …
The aim of ‘DRUCK-Surv - Surveillance of Drugs and Chronic Infectious Diseases’ is to establish a recurring nationwide data collection on hepatitis C, B (HCV, HBV) and HIV in the context of injecting drug use in sentinel cities and regions, taking into account the findings from the DRUCK 2.0 pilot …